Algorithms to Cure: How Biopharma is Redefining Innovation with AI
Biopharma R&D faces challenges of low productivity, high failure rates, and lengthy timelines, necessitating a focus on efficiency and effectiveness. Digital Health…
Category Archive
The latest Galen Growth articles, analysis, and market perspectives about Point of View in digital health.
Browse
